pantoprazole has been researched along with Dysphonia in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Dysphonia: Difficulty and/or pain in PHONATION or speaking.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lechien, JR | 2 |
Huet, K | 2 |
Khalife, M | 2 |
Fourneau, AF | 2 |
Finck, C | 2 |
Delvaux, V | 2 |
Piccaluga, M | 2 |
Harmegnies, B | 2 |
Saussez, S | 2 |
2 other studies available for pantoprazole and Dysphonia
Article | Year |
---|---|
Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Case-Control Studies; Dysphonia; Female; Hoarseness; | 2018 |
Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients.
Topics: Diet; Dysphonia; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Pantoprazole; Phonatio | 2019 |